Refolding of a recombinant collagen-targeted TGF-β2 fusion protein expressed in Escherichia coli

Protein Expression and Purification

Volumn 11, Issue 2, 1997, Pages 169-178

  Han, Bo ^a   Hall, Frederick L ^b   Nimni, Marcel E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; MUSTELA VISON;

EID: 0031282125     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0784     Document Type: Article

References (32)

1. Massague J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:1990;597-641.
2. Massague J., Andres J., Attisano L., Cheifetz S., Lopez Casillas F., Ohtsuki M., Wrana J. L. TGF-beta receptors. Mol. Reprod. Dev. 32:1992;99-104.
3. Roberts A. B., Sporn M. B. The transforming growth factor-βs, peptide growth factors and their receptors I. Handbook Exp. Pharmacol. 95:1990;419-472.
4. Graycar J. L., Miller D. A., Arrick B. A., Lyons R. M., Moses H. L., Derynck R. Human transforming growth factor-beta-3: Recombinant expression, purification, and biological activities in comparison with transforming growth factor-beta 1 and -beta 2. Mol. Endo. 3:1989;1977-1986.
5. Qian S. W., Burmester J. K., Merwin J. R., Madri J. A., Sporn M. B., Roberts A. B. Identification of a structural domain that distinguish the action of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells. Proc. Natl. Acad. Sci. USA. 89:1992;6290-6294.
6. Merwin J. R., Roberts A., Kondaiah P., Tucker A., Madri J. Vascular cell responses to TGFβ-3 mimic of TGF-β 1 in vitro. Growth Factors. 5:1991;149-158.
7. Bourdrel L., Lin C. H., Lauren S. L., Elmore R. H., Sugarman B. J., Hu S., Westcoot K. R. Recombinant human transforming growth factor-β2: Expression by Chinese hamster ovary cells, isolation, and characterization. Protein. Express. Purif. 4:1993;130-140.
8. Williams D. C., Van-Frank R. M., Muth W. L., Burnett J. P. Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. Science. 215:1982;687-689.
9. Sun D., Piez K. A., Ogawa Y., Daviers D. R. Crsytal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science. 257:1992;369-373.
10. Schlunegger M. P., Grutter M. G. An unusual feature revealed by the crystal structure at 2.2Å resolution of human transforming growth factor-beta 2. Nature. 358:1992;430-434.
11. Anfisen C. B., Scheraga H. A. Experimental and theoretical aspects of protein folding. Advances on Protein Chemistry. 1975;Academic Press, San Diego. p. 205-299.
12. Takagi J., Asai H., Satio Y. A collagen/gelatin binding decapeptide derived from bovine peopolypeptide of von Willebrand factor. Biochemistry. 31:1992;8530-8534.
13. White B. A., Bancroft F. C. Cytoplasmic dot hybridization: Simple analysis relative mRNA levels in multiple small cell or tissue samples. J. Bio. Chem. 257:1982;8569-8572.
14. Tuan T., Cheung D. T., Wu L., Yee A., Gabriel S., Han B., Nimni E. M., Hall F. Engineering, expression and renaturation of targeted TGF-β fusion protein. Connect. Tiss. Res. 34:1996;1-9.
15. Abe M., Harpel J. G., Metz C. N., Nunes I., Loskutoff D. J., Rifkin D. B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biol. 216:1994;276-284.
16. 4. Anal. Biochem. 116:1981;69-74.
17. Nimni M. The molecular organization of collagen and its role in determining the biological properties of the connective tissue. Biorheology. 17:1980;51-82.
18. Walker K. W., Gilbert H. F. Effects of redox environment on the in vitro folding of RTEM-1 b-lactamase and Escherichia coli alkaline phosphatase. J. Biol. Chem. 269:1994;28487-28493.
19. de Gruyter W., Rudolph R., Lilie H. In vitro folding of inclusion body proteins. FASEB J. 10:1996;49-56.
20. Sather S. K., King J. Intracellular trapping of a cytoplasmic folding intermediates of the phage P22 tailpike using iodoacetamide. J. Biol. Chem. 269:1994;25268-25276.
21. Mitraki A., Haase, Pettingell C., King J. Mechanism of inclusion body formation. Protein Refolding. 1991;American Chemical Society, Washington. p. 35-49.
22. Cardamone M., Puri N. K., Brandon M. R. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. Biochemistry. 34:1995;5773-5794.
23. Hasndl C. E., Harel J., Flock J. I., Dubreuil J. D. High yields of active STb enterotoxin from a fusion protein (MBP-STb) expression in Escherichia coli. Prot. Express. Purif. 4:1993;275-281.
24. Cleland J., Hedgepeth C., Wang D. Polyethylene glycol enhanced refolding of bovine carbonic anhydrase. J. Biol. Chem. 267:1992;13327-13334.
25. Babbitt P. C., West B., Buechter D., Chen L., Kuntz I. D., Kenyon G. Active reactive kinase refolding from inclusion bosies in E. coli: Improved recovery by removal of contaminating protease. Protein Refolding. 1991;American Chemical Society, Washington. p. 153-168.
26. Schumann J., Bohm G., Schumacher G., Rudolph R., Jaenicke R. Stabilization of reatinase frompseudomonas putida. Protein Sci. 2:1993;1612-1620.
27. Gary A. M., Mason A. J. Requirement for activin A and transforming growth factor-beta1 pro-regions in homodimer assembly. Science. 247:1990;1328-1330.
28. Border W. A., Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1992;1-7.
29. Lopez C. F., Payne H. M., Andres J. L., Massague J. Betaglycan can act as a dual modulator of TGF-β access to signaling receptor: Mapping of ligand bonding and GAG attachment sites. J. Cell Biol. 124:1994;557-568.
30. Ruoalahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
31. Taipale J., Miyazono K., Hekdin C., Keski O. J. latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol. 124:1994;171-181.
32. Butzow R., Fukushima C., Twardzik D. R., Ruoslahti E. A 60 kD mediates the binding of transforming growth factor-β to cell surface and extracellular matrix proteoglycans. J. Cell Biol. 122:1993;721-727.